OSI SYSTEMS INC

OSI Systems, Inc. is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications, serving diversified markets including homeland security, healthcare, defense, and aerospace. The company operates through three divisions: Security, providing security and inspection systems, turnkey security screening solutions, and high-power radio frequency systems; Optoelectronics and Manufacturing, providing specialized electronic components and manufacturing services; and Healthcare, providing patient monitoring, cardiology, remote monitoring, and connected care systems. The security and inspection market is driven by threats of terrorism, drug and human trafficking, border security, and government mandates, with global initiatives like the European Union's Customs Control Equipment Instrument and mandates for 100% cargo scanning increasing demand. The optoelectronics market is expanding due to technological advances and the electrification and miniaturization of products, while the healthcare sector is growing due to aging populations and expanding healthcare infrastructure in developing countries, though providers face inflationary pressures and labor shortages.

The markets in which OSI Systems operates are highly competitive, with competition based on product performance, quality, price, technological capabilities, and breadth of sales and service organization. In the security and inspection market, the company offers among the widest arrays of security inspection solutions available from a single supplier, enabling unique combinations and hybrid systems. In patient monitoring, the company believes its products are easier to use due to a consistent user interface and that its systems' connectivity to hospital infrastructure is a key competitive advantage, with differentiators including SafeNSound workflow software and FDA-cleared Rothman Index clinical decision support software. In optoelectronics, there are very few significant competitors in the United States, Europe, or Asia due to the high degree of engineering expertise required, while the broader electronics manufacturing services market includes multinational corporations and regional competitors.

OSI Systems generates revenue through the design, manufacture, and sale of specialized electronic systems and components, along with related services. The Security division sells security and inspection systems and turnkey security screening solutions primarily to end-users, including government agencies and commercial customers. The Optoelectronics and Manufacturing division provides optoelectronic devices and value-added subsystems, as well as electronics manufacturing services, primarily to OEM customers. The Healthcare division sells patient monitoring, cardiology, and remote monitoring systems to hospitals, clinics, and physician offices, with associated supplies and accessories representing annuity revenue opportunities. The company also generates recurring revenue through maintenance service operations, software-as-a-service platforms for security inspection data integration, and multi-year turnkey screening contracts.

The Security division, operating primarily under the Rapiscan trade name, designs and manufactures security and inspection systems used to inspect baggage, parcels, cargo, people, vehicles, and other objects for contraband including weapons, explosives, drugs, and nuclear materials. Products include baggage and parcel inspection, cargo and vehicle inspection, hold baggage screening, people screening, radiation monitoring, explosive and narcotics trace detection, and optical inspection systems. The division also offers turnkey security screening services under the S2 trade name, including the staffing and operation of security screening checkpoints, and has expanded to manage full-service checkpoint operations at several U.S. airports under TSA's Screening Partnership Program. The division also provides high-power radio frequency systems for science, industrial, government, defense, and broadcast applications. For the fiscal year ended June 30, 2026, the Security division's direct sales to the U.S. Government were approximately $207.3 million ¹.

The Optoelectronics and Manufacturing division, operating primarily under the OSI Optoelectronics trade name, designs and manufactures optoelectronic devices including active components that detect light and convert it to electrical signals, and passive components that amplify, separate, and reflect light. The division also provides electronics manufacturing services under the trade names OSI Electronics, Altaflex, and PFC Flexible Circuits, including printed circuit board assemblies, cable and harness assemblies, custom LCD displays, and flex circuits. The Healthcare division, operating under the Spacelabs Healthcare trade name, designs and manufactures patient monitoring systems including bedside monitors such as Xprezzon and Qube, telemetry solutions, centralized surveillance solutions like Xhibit Central Station, and clinical decision support software featuring the Rothman Index. The division also offers cardiology products including Holter recorders, ambulatory blood pressure monitors, resting and stress ECG devices, and the Sentinel Cardiology Information Management System.

During the fiscal year, OSI Systems continued to execute its growth strategy, which includes capitalizing on global reach, vertical integration, the market for security and inspection systems, improving medical technologies, selectively entering new markets, and acquiring new technologies and companies. The company amended and extended its credit facility in July 2025 ². The company also continued to implement a new company-wide ERP system, which is expected to modernize and replace many existing operating and financial systems. The company's backlog totaled approximately $1.9 billion as of June 30, 2026 ³, compared to $1.8 billion as of June 30, 2025 ⁴.

In fiscal year 2026, OSI Systems reported total revenues of $1.6 billion ⁵, compared to $1.5 billion ⁶ in fiscal year 2025. Net income was $151.0 million ⁷ in fiscal year 2026, compared to $139.0 million ⁸ in fiscal year 2025. Diluted earnings per share were $9.42 ⁹ in fiscal year 2026, compared to $8.71 ¹⁰ in fiscal year 2025. The company's gross margin improved to 36.5% ¹¹ in fiscal year 2026 from 35.8% ¹² in fiscal year 2025, reflecting favorable product mix and operational efficiencies.

Management's growth strategy focuses on capitalizing on global reach, vertical integration, and the expanding market for security and inspection systems. The company intends to continue enhancing its international manufacturing and sales capabilities to take advantage of competitive labor rates, strengthen sales and marketing efforts, and reduce delivery times. The company is capitalizing on opportunities to replace, service, and upgrade existing security installations, and offering turnkey security screening solutions. The company also expects the market for software-as-a-service platforms that integrate security inspection data with related information to continue to develop and grow, and the company is a leader in developing these platforms, which are used by customs and tax authorities in the United States, Europe, Middle East, Oceania, and Latin America to screen millions of containers and vehicles.

The company intends to continue to develop new security and inspection products and technologies, including software and algorithms, through internal research and development and selective acquisitions. In the Healthcare division, the company focuses on developing patient monitoring systems, cardiology and remote monitoring products, connected care solutions, and clinical decision support, with efforts concentrated on providing products that are flexible and intuitive to use. The company also intends to selectively enter new markets that complement its existing capabilities in the design, development, and manufacture of specialized electronic systems and components, through internal growth and selective acquisitions. The company expects to continue to seek acquisition opportunities to broaden technological expertise, lower manufacturing costs, and facilitate entry into new markets.

The company's margin and cost outlook is influenced by its vertical integration strategy, which provides advantages including reduced manufacturing and delivery times, lower costs due to access to competitive international labor markets, and direct sourcing of raw materials. The company continues to focus on operational efficiencies, including the implementation of a new company-wide ERP system, which is expected to modernize and replace many existing operating and financial systems. The company also continues to take actions to mitigate cost pressures from tariffs, including accelerating, increasing, or canceling inventory, diversifying suppliers, re-sourcing to countries with lower tariffs, working with factory partners to reduce costs, identifying further cost reductions, planning for strategic price increases, and pursuing potential tariff refunds.

The company's operational outlook includes continued investment in its global manufacturing organization, which has expertise in optoelectronics, microelectronics, and integrated electronics. The company manufactures security and inspection systems in California, Massachusetts, Germany, Malaysia, and the United Kingdom, RF products in Texas, patient monitoring systems in Washington state, and optoelectronic devices and electronics manufacturing services in California, New Jersey, Canada, Mexico, India, Indonesia, Malaysia, and the United Kingdom. The company is in the process of implementing a new company-wide ERP system, which is a major undertaking from a financial management and personnel perspective, and expects to incur additional capital outlays and expenses. The company also continues to modernize and upgrade its information technology systems while integrating systems from acquisitions.

The company's capital allocation priorities include continued investment in research and development, which is considered an important element of its business and operations. The company also expects to continue to seek acquisition opportunities to broaden its technological expertise and capabilities. The company's credit facility contains covenants that limit its ability to pay dividends on common stock, make certain investments, repurchase or redeem capital stock, and make certain capital expenditures. The company has outstanding 2.25% Convertible Senior Notes due 2029 and 0.50% Convertible Senior Notes due 2031, which may dilute stockholders' ownership interests upon conversion.

The company faces several headwinds and constraints, including the impact of tariffs imposed by the U.S. Government and potential retaliatory actions by other countries, which may materially increase costs and reduce margins. The company is actively monitoring the impact of tariffs and taking actions to mitigate cost pressure, but there can be no assurance that these measures will be successful or offset the negative impact. Geopolitical instability and conflicts in the Middle East and between Russia and Ukraine have created economic and political uncertainties that could disrupt operations, supply chains, and financial performance. The company also faces risks from unfavorable currency exchange rate fluctuations, which could have a material adverse effect on its business, financial condition, and results of operations.

The company's growth is also constrained by the lengthy and unpredictable sales cycles for security and inspection systems and turnkey security screening solutions, which often depend on government decisions to upgrade or expand facilities. The company may expend significant financial and management resources during approval periods in anticipation of future revenues that may not occur. Additionally, the company faces risks from the loss of certain customers, including government agencies that can modify or terminate agreements more easily than commercial customers, and the failure to continue to diversify its customer base could have a material adverse effect on its business. The company also faces risks from the consolidation of the healthcare industry, which has increased the purchasing power of larger customers and may exert downward pressure on product pricing.

The company faces significant product and professional liability risks if its security and inspection systems fail to detect weapons, explosives, or other contraband used in a terrorist act or crime, and adequate insurance coverage may not be available. The loss of certain customers, including U.S. government agencies that can terminate contracts for convenience, could have a material adverse effect, with direct sales to the U.S. Government of approximately $207.3 million in fiscal year 2026. The company is exposed to risks from tariffs and trade restrictions, which may materially increase costs and reduce margins, and the impact is uncertain but could be material. The company's operations in Mexico involve risks including the ability of suppliers to fulfill obligations, cooperation of government departments, timely payments, significant penalties for late delivery, and high crime rates. The company's indebtedness, including the 2.25% Convertible Senior Notes due 2029 and 0.50% Convertible Senior Notes due 2031, could limit cash flow available for operations and expose the company to risks that could adversely affect its business, and the conversion of the notes may dilute stockholders' ownership interests.

Management's message emphasizes the company's primary competitive strength in designing and manufacturing cost-effective specialized electronic systems and components for critical applications, and its strategy to leverage this expertise to gain price, performance, and agility advantages over competitors in the security, healthcare, and optoelectronics fields. The key elements of the growth strategy include capitalizing on global reach, vertical integration, the market for security and inspection systems, improving and complementing existing medical technologies, selectively entering new markets, and acquiring new technologies and companies. Management highlights the company's leadership in developing software-as-a-service platforms for security inspection data integration, which are used by customs and tax authorities in the United States, Europe, Middle East, Oceania, and Latin America to screen millions of containers and vehicles. The company also emphasizes its commitment to research and development, with an active program for the development and introduction of new products and enhancements, and its intention to continue to seek acquisition opportunities to broaden technological expertise and capabilities.